Monte Rosa Therapeutics, Inc. GLUE
10.53 USD -0.05 (-0.52%)
Nov 10, 2026, 11:49 AM EST
10.40 Day range 10.85
9.68 52-week range 25.77
- YTD
- -32.88%
- 1 year
- -25.14%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 123.67M | 75.62M | 0 | 0 | 0 | |
| 123.67M | 75.62M | 0 | 0 | 0 | |
| -54.21M | -81.11M | -143.31M | -112.38M | -72.88M | |
| -38.63M | -72.70M | -135.35M | -108.50M | -73.96M | |
| -0.46 | -0.98 | -2.63 | -2.30 | -2.96 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 134.84M | 229.12M | 132.68M | 55.87M | 346.07M | |
| 448.66M | 438.73M | 303.75M | 342.39M | 366.33M | |
| 215.60M | 215.80M | 124.50M | 70.98M | 18.81M | |
| 39.19M | 42.72M | 46.04M | 47.00M | 0 | |
| 233.06M | 222.94M | 179.25M | 271.41M | 347.51M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -22.80M | 42.00M | -43.80M | -92.47M | -59.36M | |
| -101.83M | -44.45M | 88.80M | -219.22M | -9.65M | |
| 30.35M | 98.89M | 27.49M | 20.47M | 377.56M | |
| -4.70M | -3.99M | -18.98M | -12.80M | -9.65M | |
| -94.28M | 96.44M | 72.49M | -291.22M | 308.55M |